Fundraising Fox

Zenflow

YC W15

San Francisco, US · Founded 2014 · Delaware corporation · 18 employees · 8 known investors

zenflow.com

Zenflow develops medical devices for treating benign prostatic hyperplasia (BPH) in men, founded from the Stanford Byers Center for Biodesign with a team experienced in medical device development and FDA regulation.

Founders & leadership· Y Combinator alumni (W15)

SMShreya Mehta
Shreya MehtainFounder/CTO
JB
John BeckExecutive Officer
ND
Nick DamianoExecutive Officer, Director
BK
Bryan KimDirector
BR
Blayne RoederDirector
SS
Susan StimsonDirector
RC
Radu CautisDirector
AC
Andrew CleelandDirector

Investors · 8

Competitors · 10

by search overlap

Companies competing with Zenflow for the same Google search keywords, organic and paid, via search-intersection analysis.

Reported raises · per SEC filings

Form D private placements
$19.4MraisedNov 2024 · 36 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Susan StimsonDirector
  • Bryan KimDirector
  • John BeckExecutive Officer
  • Radu CautisDirector
  • Andrew CleelandDirector
  • Robert WeisskoffDirector
  • Blayne RoederDirector
  • Shreya MehtaExecutive Officer, Director
Offering amount
$25.2M
Amount sold
$19.4M
Minimum investment
$1
First sale
Nov 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$24.4MraisedMay 2021 · 43 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Shreya MehtaExecutive Officer, Director
  • Bryan KimDirector
  • Nick DamianoExecutive Officer, Director
  • Radu CautisDirector
  • Robert WeisskoffDirector
  • Andrew CleelandDirector
Offering amount
$24.4M
Amount sold
$24.4M
Minimum investment
$1
First sale
Apr 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$31.5MraisedDec 2017 · 86 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Shreya MehtaExecutive Officer, Director
  • Bryan KimDirector
  • Nicholas DamianoExecutive Officer, Director
  • Robert WeisskoffDirector
  • Radu CautisDirector
Offering amount
$32.2M
Amount sold
$31.5M
Minimum investment
$1
First sale
Sep 2017
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news